Hospitals around the globe are searching for ways to improve quality of care and promote effective quality improvements (QI) strategies. Today’s hospitals have a remarkable intensity of motivation and commitment to ensuring high-quality care and fulfilling the QI mission, and rightfully so, there is a growing movement to tie reimbursement to quality performance and outcomes.

A growing number of hospitals not only collect data on outcomes and cost, but also track the number of surgeries, tests and other procedures to identify each step in the process where less-than-optimal medicine is practiced. Deficiencies in outcomes are no longer hidden or ignored, but instead, top hospitals are using this information to inspire corrective actions and accountability.

Recent studies have shown that effective problem-solving leads to the development of evidence-based protocols and critical paths, and enhanced efficiencies, such as reduced errors related to standardization of supplies and procedures.*

Heart Bypass Surgery
Heart Bypass Surgery

Hospitals with the best quality performance scores also provide their physicians, and other staff with the tools and support they need to practice high-quality medicine on a daily basis and to identify and investigate quality problems when they do appear. This includes guidelines, protocols and access to products to improve surgical procedures and patient outcomes – both in-hospital and post-discharge.

Because more than 234 million surgical procedures are performed around the world each year, even small improvements in efficacy – through quality improvement or other means – would be associated with substantial savings at the population level.

Somahlution understands the unique needs of hospitals – large and small, urban and rural, teaching and non-teaching, profit and not-for-profit. We are dedicated to developing innovative products with quality and performance goals in mind.

Somahlution’s products have not only been developed with quality and performance in mind, but also with improving patient safety, patient outcomes and reducing hospital and surgeon liabilities associated with the use of unapproved and unproven and often cytocidal pharmacy-compounded mixtures.